4//SEC Filing
Bhavnagri Veer 4
Accession 0001214659-21-006631
CIK 0001737287other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:00 PM ET
Size
8.5 KB
Accession
0001214659-21-006631
Insider Transaction Report
Form 4
Bhavnagri Veer
General Counsel
Transactions
- Sale
Common Stock
2021-06-15$25.32/sh−5,000$126,600→ 421,353 total - Exercise/Conversion
Common Stock
2021-06-15$2.27/sh+5,000$11,350→ 426,353 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-15−5,000→ 127,300 totalExercise: $2.27Exp: 2028-06-25→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020.
- [F2]25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001808980
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:00 PM ET
- Size
- 8.5 KB